KGS ▲ | Kinase Name | Entrez Gene Symbol |
ABL1(E255K)-phosphorylated | c-abl oncogene 1, receptor tyrosine kinase | ABL1 |
ABL1(T315I)-phosphorylated | c-abl oncogene 1, receptor tyrosine kinase | ABL1 |
ABL1-nonphosphorylated | c-abl oncogene 1, receptor tyrosine kinase | ABL1 |
ABL1-phosphorylated | c-abl oncogene 1, receptor tyrosine kinase | ABL1 |
ACVR1B | activin A receptor, type IB | ACVR1B |
ADCK3 | coenzyme Q8A | CABC1 |
AKT1 | v-akt murine thymoma viral oncogene homolog 1 | AKT1 |
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | AKT2 |
ALK | anaplastic lymphoma receptor tyrosine kinase | ALK |
AURKA | aurora kinase A | AURKA |
AURKB | aurora kinase B | AURKB |
AXL | AXL receptor tyrosine kinase | AXL |
BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | BMPR2 |
BRAF | v-raf murine sarcoma viral oncogene homolog B1 | BRAF |
BRAF(V600E) | v-raf murine sarcoma viral oncogene homolog B1 | BRAF |
BTK | Bruton agammaglobulinemia tyrosine kinase | BTK |
CDK11 | cyclin-dependent kinase 19 | CDK19 |
CDK2 | cyclin-dependent kinase 2 | CDK2 |
CDK3 | cyclin-dependent kinase 3 | CDK3 |
CDK7 | cyclin-dependent kinase 7 | CDK7 |
CDK9 | cyclin-dependent kinase 9 | CDK9 |
CHEK1 | checkpoint kinase 1 | CHEK1 |
CSF1R | colony stimulating factor 1 receptor | CSF1R |
CSNK1D | casein kinase 1, delta | CSNK1D |
CSNK1G2 | casein kinase 1, gamma 2 | CSNK1G2 |
DCAMKL1 | doublecortin-like kinase 1 | DCLK1 |
DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | DYRK1B |
EGFR | epidermal growth factor receptor | EGFR |
EGFR(L858R) | epidermal growth factor receptor | EGFR |
EPHA2 | EPH receptor A2 | EPHA2 |
ERBB2 | erb-b2 receptor tyrosine kinase 2 | ERBB2 |
ERBB4 | erb-b2 receptor tyrosine kinase 4 | ERBB4 |
ERK1 | mitogen-activated protein kinase 3 | MAPK3 |
FAK | PTK2 protein tyrosine kinase 2 | PTK2 |
FGFR2 | fibroblast growth factor receptor 2 | FGFR2 |
FGFR3 | fibroblast growth factor receptor 3 | FGFR3 |
FLT3 | fms-related tyrosine kinase 3 | FLT3 |
GSK3B | glycogen synthase kinase 3 beta | GSK3B |
IGF1R | insulin-like growth factor 1 receptor | IGF1R |
IKK-alpha | conserved helix-loop-helix ubiquitous kinase | CHUK |
IKK-beta | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | IKBKB |
INSR | insulin receptor | INSR |
JAK2(JH1domain-catalytic) | Janus kinase 2 | JAK2 |
JAK3(JH1domain-catalytic) | Janus kinase 3 | JAK3 |
JNK1 | mitogen-activated protein kinase 8 | MAPK8 |
JNK2 | mitogen-activated protein kinase 9 | MAPK9 |
JNK3 | mitogen-activated protein kinase 10 | MAPK10 |
KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | KIT |
KIT(D816V) | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | KIT |
KIT(V559D,T670I) | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | KIT |
LKB1 | serine/threonine kinase 11 | STK11 |
MAP3K4 | mitogen-activated protein kinase kinase kinase 4 | MAP3K4 |
MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | MAPKAPK2 |
MARK3 | MAP/microtubule affinity-regulating kinase 3 | MARK3 |
MEK1 | mitogen-activated protein kinase kinase 1 | MAP2K1 |
MEK2 | mitogen-activated protein kinase kinase 2 | MAP2K2 |
MET | met proto-oncogene (hepatocyte growth factor receptor) | MET |
MKNK1 | MAP kinase interacting serine/threonine kinase 1 | MKNK1 |
MKNK2 | MAP kinase interacting serine/threonine kinase 2 | MKNK2 |
MLK1 | mitogen-activated protein kinase kinase kinase 9 | MAP3K9 |
p38-alpha | mitogen-activated protein kinase 14 | MAPK14 |
p38-beta | mitogen-activated protein kinase 11 | MAPK11 |
PAK1 | p21 protein (Cdc42/Rac)-activated kinase 1 | PAK1 |
PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | PAK2 |
PAK4 | p21 protein (Cdc42/Rac)-activated kinase 4 | PAK4 |
PCTK1 | cyclin-dependent kinase 16 | CDK16 |
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | PDGFRA |
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | PDGFRB |
PDPK1 | 3-phosphoinositide dependent protein kinase-1 | PDPK1 |
PIK3C2B | phosphoinositide-3-kinase, class 2, beta polypeptide | PIK3C2B |
PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | PIK3CA |
PIK3CG | phosphoinositide-3-kinase, catalytic, gamma polypeptide | PIK3CG |
PIM1 | pim-1 oncogene | PIM1 |
PIM2 | pim-2 oncogene | PIM2 |
PIM3 | pim-3 oncogene | PIM3 |
PKAC-alpha | protein kinase, cAMP-dependent, catalytic, alpha | PRKACA |
PLK1 | polo-like kinase 1 | PLK1 |
PLK3 | polo-like kinase 3 | PLK3 |
PLK4 | polo-like kinase 4 | PLK4 |
PRKCE | protein kinase C, epsilon | PRKCE |
RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | RAF1 |
RET | ret proto-oncogene | RET |
RIOK2 | RIO kinase 2 | RIOK2 |
ROCK2 | Rho-associated, coiled-coil containing protein kinase 2 | ROCK2 |
RSK2(Kin.Dom.1-N-terminal) | ribosomal protein S6 kinase, 90kDa, polypeptide 3 | RPS6KA3 |
SNARK | NUAK family, SNF1-like kinase, 2 | NUAK2 |
SRC | SRC proto-oncogene, non-receptor tyrosine kinase | SRC |
SRPK3 | SFRS protein kinase 3 | SRPK3 |
TGFBR1 | transforming growth factor, beta receptor 1 | TGFBR1 |
TIE2 | TEK tyrosine kinase, endothelial | TEK |
TRKA | neurotrophic tyrosine kinase, receptor, type 1 | NTRK1 |
TSSK1B | testis-specific serine kinase 1B | TSSK1B |
TYK2(JH1domain-catalytic) | tyrosine kinase 2 | TYK2 |
ULK2 | unc-51-like kinase 2 | ULK2 |
VEGFR2 | kinase insert domain receptor (a type III receptor tyrosine kinase) | KDR |
YANK3 | serine/threonine kinase 32C | STK32C |
ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | ZAP70 |